Science Explorer Interactive view Map
Company · New York · United States

Immtech Pharmaceuticals (United States)

immtechpharma.comROR OpenAlex
Research works
20
▼ 78% vs 2013–17
Citations
1.2k
56.4 per fractional work
Top-10% rate
65.0%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Immtech Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Immtech Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Epidemiology, Hemostasis, Innate Immunity, Pathogenesis, Insulin Resistance, C-Reactive Protein and Obesity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Inflammation5▲ 10×16 topics
  2. Epidemiology3▲ 3.4×11 topics
  3. Hemostasis2▲ 54×3 topics
  4. Innate Immunity2▲ 22×6 topics
  5. Insulin Resistance2▲ 15×2 topics
  6. Pathogenesis2▲ 13×3 topics
  7. C-Reactive Protein1▲ 78×2 topics
  8. Cardiovascular Disease1▲ 5.7×2 topics
  9. Financial Performance1▲ 21×2 topics
  10. Obesity1▲ 8.7×2 topics
  11. Adipokines1▲ 139×1 topic
  12. Adipose Tissue1▲ 98×1 topic
  13. Fibrinogen1▲ 156×1 topic
  14. Transglutaminases1▲ 156×1 topic
  15. Virulence Factors1▲ 26×2 topics

Which research topics does Immtech Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Bacterial Genetics and Biotechnology, Legume Nitrogen Fixing Symbiosis, Enzyme Production and Characterization and Monoclonal and Polyclonal Antibodies Research.

  1. 1 Bacterial Genetics and Biotechnology Genetics 0 works
  2. 2 Legume Nitrogen Fixing Symbiosis Plant Science 0 works
  3. 3 Enzyme Production and Characterization Biotechnology 0 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 0 works
  6. 6 Protein purification and stability Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.3%not open46.7%

World: 28% of research is openly available.

with international co-authors30.4%domestic only69.6%

World: 19% is written across borders.

How has Immtech Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 78% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New York

All research institutions in New York

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.